An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs

被引:395
作者
Ong, C. K. S. [1 ]
Lirk, P. [2 ]
Tan, C. H. [3 ]
Seymour, R. A. [4 ]
机构
[1] Natl Univ Singapore, Fac Dent, Dept Oral & Maxillofacial Surg, Singapore, Singapore
[2] Med Univ Innsbruck, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria
[3] Natl Univ Singapore, Fac Med, Dept Pharmacol, Singapore, Singapore
[4] Newcastle Univ, Sch Dent Sci, Dept Dent Pharmacol, Newcastle Upon Tyne, Tyne & Wear, England
关键词
Analgesics; COX-2 specific inhibitors; NSAIDs; Pain;
D O I
10.3121/cmr.2007.698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonsteroidal anti-inflammatory drugs (NSAIDs), including both traditional nonselective NSAIDs and the selective cyclooxygenase (COX)-2 inhibitors, are widely used for their anti-inflammatory and analgesic effects. NSAIDs are a necessary choice in pain management because of the integrated role of the COX pathway in the generation of inflammation and in the biochemical recognition of pain. This group of drugs has recently come under scrutiny because of recent focus in the literature on the various adverse effects that can occur when applying NSAIDs. This review will provide an educational update on the current evidence of the efficacy and adverse effects of NSAIDs. It aims to answer the following questions: (1) are there clinically important differences in the efficacy and safety between the different NSAIDs, (2) if there are differences, which are the ones that are more effective and associated with fewer adverse effects, and (3) which are the effective therapeutic approaches that could reduce the adverse effects of NSAIDs. Finally, an algorithm is proposed which delineates a general decision-making tree to select the most appropriate analgesic for an individual patient based on the evidence reviewed.
引用
收藏
页码:17 / 32
页数:16
相关论文
共 111 条
  • [1] Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors
    Battistella, M
    Mamdami, MM
    Juurlink, DN
    Rabeneck, L
    Laupacis, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (02) : 189 - 192
  • [2] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    Day, R
    Ferraz, MB
    Hawkey, CJ
    Hochberg, MC
    Kvien, TK
    Schnitzer, TJ
    Weaver, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
  • [3] Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
    Borer, JS
    Simon, LS
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 4) : S14 - S22
  • [4] COMPARISON OF AN ANTIINFLAMMATORY DOSE OF IBUPROFEN, AN ANALGESIC DOSE OF IBUPROFEN, AND ACETAMINOPHEN IN THE TREATMENT OF PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
    BRADLEY, JD
    BRANDT, KD
    KATZ, BP
    KALASINSKI, LA
    RYAN, SI
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (02) : 87 - 91
  • [5] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
    Bresalier, RS
    Sandler, RS
    Quan, H
    Bolognese, JA
    Oxenius, B
    Horgan, K
    Lines, C
    Riddell, R
    Morton, D
    Lanas, A
    Konstam, MA
    Baron, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) : 1092 - 1102
  • [6] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson, F
    Reilly, MP
    Kapoor, SC
    Cucchiara, AJ
    DeMarco, S
    Tournier, B
    Vyas, SN
    FitzGerald, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) : 1809 - 1817
  • [7] Long-term use and tolerability of cyclooxygenase-2 inhibitors in patients with analgesic intolerance
    Çelik, G
    Erkekol, FÖ
    Bavbek, S
    Dursun, B
    Misirligil, Z
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 95 (01) : 33 - 37
  • [8] Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance
    Çelik, G
    Pasaoglu, G
    Bavbek, S
    Abadoglu, Ö
    Dursun, B
    Mungan, D
    Misirligil, Z
    [J]. JOURNAL OF ASTHMA, 2005, 42 (02) : 127 - 131
  • [9] Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment
    Chan, FKL
    Graham, DY
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (10) : 1051 - 1061
  • [10] Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis
    Chan, FKL
    Hung, LCT
    Suen, BY
    Wu, JCY
    Lee, KC
    Leung, VKS
    Hui, AJ
    To, KF
    Leung, WK
    Wong, VWS
    Chung, SCS
    Sung, JJY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26) : 2104 - 2110